Legal Representation
Attorney
Matthew D. Asbell
USPTO Deadlines
Next Deadline
79 days remaining
Notification of Non-Final Action E-Mailed
Due Date
September 30, 2025
Extension Available
Until December 30, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
8 eventsDate | Code | Type | Description |
---|---|---|---|
Jun 30, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED |
Jun 30, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN |
Jun 30, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Jun 26, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
Jun 23, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Jun 23, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Jan 17, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
Jan 17, 2025 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
chemical preparations for pharmaceutical or medical purposes, namely, for cardiovascular disorders and diseases, skeletal muscle disorders and diseases, muscle fatigue, cognitive disorders and bone disorders; pharmaceutical preparations for the treatment and prevention of cardiovascular disorders and diseases, skeletal muscle disorders and diseases, muscle fatigue, cognitive disorders and bone disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for restoring normal intracellular calcium regulation; pharmaceutical preparations for that restoring normal intracellular calcium regulation; a full line of medicinal and pharmaceutical preparations
Class 042
Pharmaceutical research and development
Additional Information
Design Mark
The mark consists of curved line forming an abstract, looping shape with two overlapping loops.
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
No claim is made to the exclusive right to use Therapeutics, apart from the mark as shown.
USPTO Documents
Loading USPTO documents...